Search results for: methotrexate

Is Predisone 3 mg/day an Appropriate Dose for Patients with Rheumatoid Arthritis?

Theodore Pincus, MD | April 1, 2013

Long-term, low-dose prednisone at less than 5 mg/day appears tolerable and effective for many patients with rheumatoid arthritis (RA)

Why Oral Corticosteroids Should Not be Used in Patients with Rheumatoid Arthritis

Anthony S. Russell, MA, MB, BCHIR | April 1, 2013

Steroid use in patients with rheumatoid arthritis (RA) has been linked to higher mortality rates, greater rate of infections, more cases of pneumonia, and serious gastrointestinal events

Rheuminations: Epigenetics May Help to Explain Why Some Get Rheumatic Disease

Simon M. Helfgott, MD | March 1, 2013

Recent research around genes and environmental stresses suggests outside influences can make lasting changes to the genome via epigenetic mechanisms

ACR/ARHP Annual Meeting 2012: Risk of Immunosuppression from Rheumatic Disease Therapies Poses Challenge for Rheumatologists

Susan Bernstein | March 1, 2013

Therapies can raise patients’ risk of contracting tuberculosis or other infectious diseases, complicating treatment

Rheumatology Drug Updates

Michele B. Kaufman, PharmD, BCGP | March 1, 2013

Information on new approvals and medication safety that rheumatologists need to know

Two Inflammatory Conditions—Polymyalgia Rheumatica and Giant Cell Arteritis—Share Clinical Connection

William P. Docken MD | March 1, 2013

Polymyalgia rheumatica (PMR) and giant cell arteritis (GCA) have common clinical and epidemiologic links, but they need not occur synchronously

Rheumatology Chooses Wisely

Kurt Ullman | February 22, 2013

ACR identifies five practices, therapies, or procedures physicians and patients should question

What Mick Jagger Can Teach Us About Growing Old Gracefully

Simon M. Helfgott, MD | February 1, 2013

Preventive lifestyle behaviors, including regular exercise, can compress morbidity and disability to the very end of our lives, say rheumatologists

ACR/ARHP Annual Meeting 2012: Rheumatologists Take Proactive Approach in Talking with Teen Patients about Risky Behavior

Susan Bernstein | February 1, 2013

With teenaged juvenile arthritis patients, it’s important for rheumatologists to engage in conversations about how drugs, tobacco, alcohol, and sex will affect them

ACR/ARHP Annual Meeting 2012: Immunosuppressed Rheumatic Disease Patients Still Candidates for Vaccines

Thomas R. Collins | February 1, 2013

People with rheumatic diseases can be considered to receive flu and pneumococcal vaccines even if they’re on immunosuppressive drugs